Successful azacitidine based treatment of therapy related myelodysplastic syndrome with normal karyotype occurred after acute myeloid leukemia

被引：0
|
作者：
Saltarelli, F. [1 ]
Tatarelli, C. [1 ]
Spiriti, M. A. Aloe [1 ]
Naso, V. [1 ]
Bianchi, M. P. [1 ]
Bianchi, M. P. [1 ]
Conte, E. [1 ]
Proia, S. [1 ]
Ferrari, A. [1 ]
机构：
[1] Univ Roma La Sapienza, S Andrea Hosp, Hematol, I-00185 Rome, Italy
来源：
LEUKEMIA RESEARCH | 2013年 / 37卷
关键词：
D O I：
10.1016/S0145-2126(13)70241-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-194
引用
收藏
页码：S110 / S111
页数：2
相关论文
共 50 条
  • [1] SUCCESSFULL AZACITIDINE BASED TREATMENT OF THERAPY RELATED MYELODYSPLASTIC SYNDROME WITH NORMAL KARYOTYPE OCCURRED AFTER ACUTE MYELOID LEUKEMIA
    Saltarelli, F.
    Tatarelli, C.
    Naso, V.
    Spiriti, M.
    Bianchi, M.
    Conte, E.
    Ferrari, A.
    HAEMATOLOGICA, 2013, 98 : 590 - 590
  • [2] AZACITIDINE FOR ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME
    Gritsaev, S., V
    Martynkevich, I. S.
    Kostroma, I. I.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2012, 57 (01): : 23 - 29
  • [3] THERAPY-RELATED MYELODYSPLASTIC SYNDROME AFTER THE SUCCESSFUL TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA
    Malkan, Umit Yavuz
    Gunes, Gursel
    Yayar, Okan
    Aksu, Salih
    Demiroglu, Haluk
    Haznedaroglu, Ibrahim Celalettin
    LEUKEMIA RESEARCH, 2015, 39 : SS36 - SS37
  • [4] Frequent genomic abnormalities in acute myeloid leukemia/myelodysplastic syndrome with normal karyotype
    Akagi, Tadayuki
    Ogawa, Seishi
    Dugas, Martin
    Kawamata, Norihiko
    Yamamoto, Go
    Nannya, Yasuhito
    Sanada, Masashi
    Miller, Carl W.
    Yung, Amanda
    Schnittger, Susanne
    Haferlach, Torsten
    Haferlach, Claudia
    Koeffler, H. Phillip
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (02): : 213 - 223
  • [5] Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2)
    Ogasawara, T
    Yasuyama, M
    Kawauchi, K
    AMERICAN JOURNAL OF HEMATOLOGY, 2005, 79 (02) : 136 - 141
  • [6] SUCCESSFUL RETREATMENT WITH AZACITIDINE OF A PATIENT WITH ACUTE MYELOID LEUKEMIA TRANSFORMED FROM MYELODYSPLASTIC SYNDROME AFTER THE SUSPENSION OF THIS AGENT
    Niscola, P.
    Piccioni, D.
    Tendas, A.
    Cupelli, L.
    Scaramucci, L.
    Giovannini, M.
    Fratoni, S.
    de Fabritiis, P.
    HAEMATOLOGICA, 2015, 100 : 103 - 103
  • [7] Differentiation syndrome in acute myeloid leukemia after treatment with azacitidine
    Laufer, Christin B.
    Roberts, Owen
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 95 (05) : 484 - 485
  • [8] Clonal selection in therapy-related myelodysplastic syndromes and acute myeloid leukemia under azacitidine treatment
    Calleja, Anne
    Yun, Seongseok
    Moreilhon, Chimene
    Karsenti, Jean Michel
    Gastaud, Lauris
    Mannone, Lionel
    Komrokji, Rami
    al Ali, Najla
    Dadone-montaudie, Berangere
    Robert, Guillaume
    Auberger, Patrick
    Raynaud, Sophie
    Sallman, David A.
    Cluzeau, Thomas
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 104 (05) : 488 - 498
  • [9] SUCCESSFUL RE-TREATMENT WITH AZACITIDINE IN A PATIENT WITH MYELODYSPLASTIC SYNDROME (MDS) EVOLUTED INTO ACUTE MYELOID LEUKEMIA (AML) AFTER THE SUSPENSION OF THIS AGENT
    Niscola, P.
    Tendas, A.
    Cupelli, L.
    Scaramucci, L.
    Giovannini, M.
    Fratoni, S.
    de Fabritiis, P.
    LEUKEMIA RESEARCH, 2015, 39 : S137 - S138
  • [10] Azacitidine for Treatment of Therapy Related Myelodysplastic Syndrome
    Komrokji, Rami S.
    Al Ali, Najla H.
    Alrawi, E.
    Padron, Eric
    Perkins, Janelle
    Field, Teresa
    Lancet, Jeffrey E.
    List, Alan F.
    BLOOD, 2011, 118 (21) : 745 - 746
12345